Further analysis did, however, reveal that LMO2 intron variants were significantly associated with “Cause of death: cardiomegaly” (p = 3.0−9) and “Cause of death: dilated cardiomyopathy” (p = 1.3−8). This evidence concerns the gene LMO2 and cardiac hypertrophy.